News
SCNI
3.441
+0.63%
0.021
Weekly Report: what happened at SCNI last week (0106-0110)?
Weekly Report · 2d ago
Weekly Report: what happened at SCNI last week (1230-0103)?
Weekly Report · 01/06 09:36
Weekly Report: what happened at SCNI last week (1223-1227)?
Weekly Report · 12/30/2024 09:34
Weekly Report: what happened at SCNI last week (1216-1220)?
Weekly Report · 12/23/2024 09:35
Scinai Immunotherapeutics Announces The Establishment Of A U.S.-Based Subsidiary For Its Contract Development And Manufacturing Services
Benzinga · 12/16/2024 14:26
Weekly Report: what happened at SCNI last week (1209-1213)?
Weekly Report · 12/16/2024 09:36
Weekly Report: what happened at SCNI last week (1202-1206)?
Weekly Report · 12/09/2024 09:35
Weekly Report: what happened at SCNI last week (1125-1129)?
Weekly Report · 12/02/2024 09:35
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 11/26/2024 21:06
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 11/25/2024 21:05
Scinai Immunotherapeutics Reports Financial Turnaround and Growth
TipRanks · 11/25/2024 14:54
Weekly Report: what happened at SCNI last week (1118-1122)?
Weekly Report · 11/25/2024 09:34
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 11/22/2024 21:06
Scinai Immunotherapeutics Gains Shareholder Confidence
TipRanks · 11/22/2024 13:57
Weekly Report: what happened at SCNI last week (1111-1115)?
Weekly Report · 11/18/2024 09:33
Weekly Report: what happened at SCNI last week (1104-1108)?
Weekly Report · 11/11/2024 09:36
Weekly Report: what happened at SCNI last week (1028-1101)?
Weekly Report · 11/04/2024 09:36
Weekly Report: what happened at SCNI last week (1021-1025)?
Weekly Report · 10/28/2024 09:33
Weekly Report: what happened at SCNI last week (1014-1018)?
Weekly Report · 10/21/2024 09:33
Scinai Immunotherapeutics to Hold Annual Shareholder Meeting
TipRanks · 10/15/2024 19:57
More
Webull provides a variety of real-time SCNI stock news. You can receive the latest news about Scinai Immunotherapeutics Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About SCNI
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.